You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,301,023


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,301,023
Patent landscape, scope, and claims:
Title:Chiral salt resolution
Abstract: A method for resolving enantiomers of a compound containing the structure of the forula: ##STR00001## wherein R.sup.4 or R.sup.5 may contan one or more asymmetric centers, by mixing a racemic mixture of enantiomers of a compound, containing the structure of said formula; in a solvent, with a resolving compound having a defined sterospecificity, to form a solution and with said resolving agent being capable of binding with at least one but not all of said enantiomers to form a precipitate, containing said at least one of said enantiomers in sterospecific form and collecting either the precipitate and purifying it or collecting the solution with contained other of said enantiomers and recrystallizing the enantiomer contained in said solution.
Inventor(s): Flanagan; Mark E. (Gales Ferry, CT), Munchhof; Michael J. (Salem, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:10/154,699
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,301,023
Patent Claim Types:
see list of patent claims
Use; Formulation;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,301,023

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,301,023

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1666481 ⤷  Subscribe 300887 Netherlands ⤷  Subscribe
European Patent Office 1666481 ⤷  Subscribe CA 2017 00035 Denmark ⤷  Subscribe
European Patent Office 1666481 ⤷  Subscribe PA2017025 Lithuania ⤷  Subscribe
European Patent Office 1666481 ⤷  Subscribe 122017000062 Germany ⤷  Subscribe
European Patent Office 1666481 ⤷  Subscribe LUC00031 Luxembourg ⤷  Subscribe
European Patent Office 1666481 ⤷  Subscribe 2017C/032 Belgium ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.